Related Experiment Videos
F329L polymorphism in the human PAX8 gene
E Torban1, J Pelletier, P Goodyer
1Department of Experimental Medicine, McGill University, Quebec, Canada.
American Journal of Medical Genetics
|October 23, 1997
Summary
Researchers investigated the PAX8 gene in juvenile nephronophthisis patients. While no disease mutations were found, the first human PAX8 polymorphism, F329L, was identified in patients and controls.
Area of Science:
- Genetics
- Molecular Biology
- Nephrology
Background:
- Juvenile nephronophthisis is a rare genetic kidney disease.
- The PAX8 gene is located near the gene associated with this condition.
Purpose of the Study:
- To screen for mutations in the PAX8 gene in patients with juvenile nephronophthisis.
- To identify any novel genetic variations within the PAX8 gene.
Main Methods:
- Genetic screening of patients diagnosed with juvenile nephronophthisis.
- Analysis of the PAX8 gene sequence for mutations and polymorphisms.
Main Results:
- No disease-associated mutations in the PAX8 gene were detected in the patient cohort.
- The first known human PAX8 polymorphism, F329L, was identified.
- This polymorphism was found in 1 out of 15 patients and 2 out of 20 controls.
- The F329L variant represents a conservative amino acid substitution (phenylalanine to leucine) in the C-terminal region of the PAX8 protein.
Conclusions:
- The PAX8 gene is unlikely to be a primary cause of juvenile nephronophthisis.
- The identified F329L polymorphism is a common variant and not disease-specific.
- Further research may explore the functional impact of this PAX8 polymorphism.